Home News Global stocks

Avantor: Key play for investors seeking value and biotechnology exposure

Thiveyen Kathirrasan
Thiveyen Kathirrasan6/24/2022 08:16 AM GMT+08  • 3 min read
Avantor: Key play for investors seeking value and biotechnology exposure
Photo Credit: Bloomberg
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Performance: -18.0%

New York-listed Avantor Inc was among the underperformers in our portfolio for the four-month period, with a 18.0% loss. The company is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Avantor also supplies chemicals for vaccine development and manufacturing, including solutions that support Covid-19 vaccines.

The case for investing in the company is its lucrative business model and position as a key player in the value chain. Avantor’s business model is centred around high recurring revenues and strong and consistent cashflow generation. Its dynamic products and services are used in virtually every stage of the most important research & development and production activities of the industries they have a presence in. Given its global scale, along with customised solutions for clients and through its e-commerce platform, Avantor’s position as a key player in the value chain further reinforces its competitive advantage.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now